12 employees
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD.
2014
$20M
from 2 investors over 2 rounds
Azura Ophthalmics Limited raised $20M on October 22, 2020
Investors: OrbiMed Advisors
Azura Ophthalmics Limited raised $16M on October 10, 2017